References
- James AL, Chadha NK, Papsin BC, Stockley TL. Pediatric cholesteatoma and variants in the gene encoding connexin 26. Laryngoscope 2010;120:183–7.
- Juhász A, Sziklai I, Rákosy Z, Ecsedi S, Adány R, Balázs M. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas. Otol Neurotol 2009;30:559–65.
- Preciado DA. Biology of cholesteatoma: special considerations in pediatric patients. Int J Pediatr Otorhinolaryngol 2012;76:319–21.
- Zhang W, Chen X, Qin Z. MicroRNA let-7a suppresses the growth and invasion of cholesteatoma keratinocytes. Mol Med Rep 2015;11:2097–103.
- Louw L. Acquired cholesteatoma: summary of the cascade of molecular events. J Laryngol Otol 2013;127:542–9.
- Alves AL, Pereira CS, Carvalho Mde F, Fregnani JH, Ribeiro FQ. EGFR expression in acquired middle ear cholesteatoma in children and adults. Eur J Pediatr 2012;171:307–10.
- Barbara M, Raffa S, Murè C, Manni V, Ronchetti F, Monini S, et al. Keratinocyte growth factor receptor (KGF-R) incholesteatomatissue. Acta Otolaryngol 2008;128:360–4.
- Yamamoto-Fukuda T, Takahashi H, Koji T. Expression of keratinocyte growth factor (KGF) and its receptor in a middle-ear cavity problem. Int J Pediatr Otorhinolaryngol 2012;76:76–81.
- Friedland DR, Eernisse R, Erbe C, Gupta N, Cioffi JA. Cholesteatoma growth and proliferation: post transcriptional regulation by microRNA-21. Otol Neurotol 2009;30:998–1005.
- Chen X, Qin Z. Post-transcriptional regulation by microrna-21 and let-7a microRNA in paediatric cholesteatoma. J Int Med Res 2011;39:2110–18.
- Djuranovic S, Nahvi A, Green R. A parsimonious model for gene regulation by miRNAs. Science 2011;331:550–3.
- Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281–97.
- Akimoto R, Pawankar R, Yagi T, Baba S. Acquired and congenital cholesteatoma: determination of tumor necrosis factor-alpha, intercellular adhesionmolecule-1, interleukin-1-alpha and lymphocyte functional antigen-1 in the inflammatory process. ORL J Otorhinolaryngol Relat Spec 2000;62:257–65.
- Bujía J, Kim C, Boyle D, Hammer C, Firestein G, Kastenbauer E. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma. Laryngoscope 1996;106:217–20.
- Bujía J, Kim C, Ostos P, Sudhoff H, Kastenbauer E, Hültner L. Interleukin 1 (IL-1) and IL-1-receptor antagonist (IL-1-RA) in middle ear cholesteatoma: an analysis of proteinproduction and biological activity. Eur Arch Otorhinolaryngol 1996;253:252–5.
- Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 2009;8:1067–74.
- Hiyoshi Y, Kamohara H, Karashima R, Sato N, Imamura Y, Nagai Y, et al. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin Cancer Res 2009;15:1915–22.
- Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008;18:350–9.